Irinotecan Hydrochloride + Fluorouracil Interaction
Moderateinteraction on record
Description
Co-administration reduces SN-38 Cmax by 14% and AUC by 8%. This sequence is used in combination trials and is recommended.
Mechanism
Reduced active metabolite exposure when irinotecan followed by 5-FU and leucovorin
Source: NLP:irinotecan hydrochloride